MedTrace Logo

Sensitivity and Specificity of the Roth Test in Patients With COVID-19 Positive

NCT04832828 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114

Last updated 2021-04-06

No results posted yet for this study

Summary

The presence of the described silent hypoxia in subjects diagnosed with COVID19 highlights the need for valid tools to assess respiratory capacity. The Roth test has been associated with acceptable sensitivity and specificity criteria in patients with previous respiratory pathology; however, its validity in this type of patient has not been proven.

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

Roth´s Test

Subjets must count from 1 to 30 in their languages, and health professional will count seconds that last in take breath during the count.

Sponsors & Collaborators

  • Universidad Autonoma de Madrid

    lead OTHER

Eligibility

Min Age
12 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2020-11-28
Completion
2020-11-28

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04832828 on ClinicalTrials.gov